EVIDENCE

Standing Committee
on

INDUSTRY

Chairman: David Walker, Lib.

Meeting No. 48

Thursday, March 6, 1997

ORDER OF THE DAY:

Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)

WITNESSES:

Eli Lilly Canada Inc.:

Nelson M. Sims, President.

Merck Frosst Canada Inc.:

André Marcheterre, President.

Pharmaceutical Manufacturers' Association of Canada:

Judy Erola, President;

Emma Grell, Legal Counsel;

Paul Lucas, Representative;

Nelson M. Sims, Chairman of the Board.

;